Your browser doesn't support javascript.
loading
MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
Li, Yawen; Quan, Jing; Chen, Fangfang; Pan, Xiang; Zhuang, Changshui; Xiong, Tiefu; Zhuang, Chengle; Li, Jianfa; Huang, Xinbo; Ye, Jing; Zhang, Fangting; Zhang, Zeng; Gui, Yaoting.
Afiliação
  • Li Y; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Quan J; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Chen F; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Pan X; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Zhuang C; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Xiong T; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Zhuang C; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Li J; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Huang X; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Ye J; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Zhang F; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China.
  • Zhang Z; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China. Electronic address: 1099732021@qq.com.
  • Gui Y; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University, Shenzhen, 518036, China. Electronic address: guiyaoting2007@aliyun.com.
Biomed Pharmacother ; 111: 517-526, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30597305

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Proteína Quinase CDC2 / Proteínas Supressoras de Tumor / MicroRNAs / Neoplasias Renais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Proteína Quinase CDC2 / Proteínas Supressoras de Tumor / MicroRNAs / Neoplasias Renais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2019 Tipo de documento: Article